A research team based in Taiwan has found a key antibody that has the ability to neutralize SARS-CoV-2, the novel coronavirus that causes COVID-19.
The team, led by Huang Kuan-ying (黃冠穎), a doctor in the Department of Pediatric Infectious Diseases at Chang Gung Memorial Hospital’s Linkou branch in New Taipei City, is comprised of researchers from the hospital, Chang Gung University, Academia Sinica and the Institute of Preventive Medicine at the National Defense Medical Center, as well as Oxford University in the UK.
The team on Thursday said that it examined antibody function through immunofluorescence assays, neutralization tests and plaque reduction neutralization tests.
Photo courtesy of Linkou Chang Gung Memorial Hospital.
Tests with strains from different clades, including strains from China, the US, Europe and Egypt, showed an equivalent neutralization effect of 90 to 98 percent, it said.
The test results demonstrated the potential of SARS-CoV-2-neutralizing human monoclonal antibodies for the development of prophylactic and therapeutic products, it added.
Chang Gung University Research Center for Emerging Viral Infections director Shih Shin-ru (施信如) said that for the coronavirus to infect the body, it has to integrate with a protein attached to the surface of human cells called angiotensin-converting enzyme 2.
The antibody discovered by the team can prevent this process by integrating with the enzyme first, thus blocking the coronavirus’ path to infection, she said.
The team plans to use the antibody to develop medication, Shih said, adding that it would next month meet with manufacturers, which would conduct further trials before beginning mass production.
If all goes well, the medicine could be on the market by the end of this year, she said.
Although the antibody has shown promising results in human cell testing, Shih said that as no clinical trials have been conducted, it is still uncertain how it would perform in COVID-19 patients.
South Korean K-pop girl group Blackpink are to make Kaohsiung the first stop on their Asia tour when they perform at Kaohsiung National Stadium on Oct. 18 and 19, the event organizer said yesterday. The upcoming performances will also make Blackpink the first girl group ever to perform twice at the stadium. It will be the group’s third visit to Taiwan to stage a concert. The last time Blackpink held a concert in the city was in March 2023. Their first concert in Taiwan was on March 3, 2019, at NTSU Arena (Linkou Arena). The group’s 2022-2023 “Born Pink” tour set a
CPBL players, cheerleaders and officials pose at a news conference in Taipei yesterday announcing the upcoming All-Star Game. This year’s CPBL All-Star Weekend is to be held at the Taipei Dome on July 19 and 20.
The Taiwan High Court yesterday upheld a lower court’s decision that ruled in favor of former president Tsai Ing-wen (蔡英文) regarding the legitimacy of her doctoral degree. The issue surrounding Tsai’s academic credentials was raised by former political talk show host Dennis Peng (彭文正) in a Facebook post in June 2019, when Tsai was seeking re-election. Peng has repeatedly accused Tsai of never completing her doctoral dissertation to get a doctoral degree in law from the London School of Economics and Political Science (LSE) in 1984. He subsequently filed a declaratory action charging that
The Hualien Branch of the High Court today sentenced the main suspect in the 2021 fatal derailment of the Taroko Express to 12 years and six months in jail in the second trial of the suspect for his role in Taiwan’s deadliest train crash. Lee Yi-hsiang (李義祥), the driver of a crane truck that fell onto the tracks and which the the Taiwan Railways Administration's (TRA) train crashed into in an accident that killed 49 people and injured 200, was sentenced to seven years and 10 months in the first trial by the Hualien District Court in 2022. Hoa Van Hao, a
RSS